Improved energetics may explain the favorable effect of insulin infusion on bupivacaine cardiotoxicity.
Weinberg
G
G
VadeBoncouer
T
T
D000779:Anesthetics, Local / Q000037:antagonists & inhibitors* / Q000633:toxicity; D000818:Animals; D002045:Bupivacaine / Q000037:antagonists & inhibitors* / Q000633:toxicity; D004285:Dogs; D004734:Energy Metabolism / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology; D006331:Heart Diseases / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000494:pharmacology*
D000779:Anesthetics, Local; D007004:Hypoglycemic Agents; D007328:Insulin; D005947:Glucose; D002045:Bupivacaine